PortViewPortView
Bausch + Lomb logo

Bausch + Lomb (BLCO) Stock Analysis

NYSEHealthcareMedical - Instruments & Supplies

$18.38+2.77%
1-year price historyRange $14.32 – $18.60
52-week range$18.38
$13.77$18.92

What Bausch + Lomb does

Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment also provides essential contact lens care products, over-the-counter eye drops, and nutritional supplements aimed at alleviating common eye conditions like allergies, conjunctivitis, and dry eye. Through its Ophthalmic Pharmaceuticals segment, the company develops and markets both proprietary and generic prescription medications. These pharmaceuticals are utilized for post-operative recovery and the treatment of various ocular diseases, such as glaucoma, ocular hypertension, and retinal disorders. Additionally, it supplies therapeutic contact lenses. The Surgical segment is dedicated to providing advanced tools and technologies for surgical interventions related to cataracts, as well as vitreous and retinal conditions. Its offerings include intraocular lenses (IOLs) with their delivery systems, phacoemulsification equipment, and a range of other specialized surgical instruments and devices. Founded in 1853, Bausch + Lomb is headquartered in Vaughan, Canada.

Key metrics

Market cap
$6.56B
P/E (TTM)
28.27
EPS (TTM)
$0.65
Beta
0.55
Dividend yield
0.00%
Revenue / share
$14.89
50-day avg
$16.67
200-day avg
$16.51
52-week high
$18.92
52-week low
$13.77
CEO
Brenton L. Saunders

ETFs linked to BLCO

Broad-market and Healthcare sector ETFs an investor holding Bausch + Lomb is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BLCO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BLCO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Bausch + Lomb?
Bausch + Lomb trades under the ticker BLCO on NYSE.
Which exchange is BLCO listed on?
BLCO is listed on NYSE.
What sector does Bausch + Lomb operate in?
Bausch + Lomb is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze BLCO in a portfolio?
PortView shows BLCO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.